He will never leave, it's his baby. It's obvious to anyone with 1/2 a brain that he's unable to be objective. He must be pushed out for shareholders to ever see any substantial pps increase. Hopefully Denner will do his job and increase ROI.
Once Ponatinib crapped out, the business model became completely unsustainable. That's why it's a $5 stock.
News 
Market Data 
Discover 
